0.3850
+0.0100
+(2.67%)
At close: April 17 at 4:10:22 PM GMT+10
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Lee Rodne | Executive Chairman | 279.58k | -- | -- |
| Mr. Jacques Schipper | Chief Financial Officer | -- | -- | -- |
| Mr. Peter McLennan | Chief Operating Officer | -- | -- | -- |
| Prof. Geoffrey A. Strange | Chief Medical Officer | -- | -- | -- |
| Mr. Danny Zanardo | Chief Commercial Officer | -- | -- | -- |
| Mr. David Hwang | Joint Company Secretary | -- | -- | -- |
| Ms. Elizabeth Spooner | Joint Company Secretary | -- | -- | -- |
LTR PHARMA FPO [LTP]
29/97 Creek Street
Brisbane, QLD 4000
Australia
- Sector:
- Healthcare
- Industry: Biotechnology
Description
LTR Pharma Limited, a biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Corporate Governance
LTR PHARMA FPO [LTP]’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
ACW.AX Actinogen Medical Limited
0.0300
+3.45%
OPT.AX Opthea Limited
0.6000
0.00%
CU6.AX Clarity Pharmaceuticals Ltd
1.9000
+13.10%
IMM.AX Immutep Limited
0.2350
+4.44%
BOT.AX Botanix Pharmaceuticals Limited
0.3950
+2.60%
OPT Opthea Limited
3.4100
+1.49%
TLX.AX Telix Pharmaceuticals Limited
25.69
-0.70%
TLX Telix Pharmaceuticals Limited
16.71
+1.03%
NEU.AX Neuren Pharmaceuticals Limited
10.53
+3.54%
IMMP Immutep Limited
1.5400
+6.21%